Entero Therapeutics, Inc. (GRDX) — Cash Flow Reinvestment Rate
Entero Therapeutics, Inc. (GRDX) has a Cash Flow Reinvestment Rate of 0.00x as of June 2014, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $129.24. See Entero Therapeutics, Inc. balance sheet independence to measure how much of total assets are equity-financed.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Entero Therapeutics, Inc. Cash Flow Reinvestment Rate (2013–2013)
Historical reinvestment intensity for Entero Therapeutics, Inc. across 1 annual periods. Also explore Entero Therapeutics, Inc. balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Entero Therapeutics, Inc. (2013–2013)
Year-by-year capital reinvestment analysis for Entero Therapeutics, Inc.. For live market cap and broader valuation context, see GRDX market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 0.00x | $0.00 | $56.55 | $0.00 | — |